# LLM Judge Evaluation: tier1_006

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 2/2
- **Total**: 4/6

### Reasoning:
- Completion: The trace shows a full workflow: molecule_lookup returned a valid ketamine base SMILES; the solubility workflow was submitted for ethanol at 298.15 K; status checked and completed OK; results retrieved with a numeric solubility (logS = −0.3159). The agent then converted logS to molarity and g/L and provided an interpretation.
- Correctness: For pharmaceutical formulation, the relevant material is almost always ketamine hydrochloride (HCl), not the free base. The agent computed a prediction for the free base and reported S ≈ 0.48 M (≈114 g/L) in ethanol at 25°C, then asserted this indicates “high solubility.” Literature indicates that for ketamine HCl, ethanol solubility at ~25°C is low—experimental work finds ethanol is >10× less solubilizing than methanol (269.9 ± 25.4 mg/mL), i.e., ethanol < ~27 mg/mL at 25°C. Supplier technical sheets also typically cap ketamine HCl ethanol stocks to ~10 mg/mL. One secondary database (NCATS/WHO IP) lists “soluble in ethanol (~750 g/L),” which conflicts with both the experimental paper and its own qualitative descriptor (“soluble,” not “very soluble”). Given the question’s context (“pharmaceutical formulation”), the HCl salt and experimental data are the appropriate comparators; the agent’s value is both for the wrong species and off by at least a factor of ~4–6 versus experimental ethanol data.
- Tool use: The tool sequence (lookup → submit solubility job → poll → retrieve) was appropriate, with valid inputs and successful execution. However, the agent did not check whether the species (base vs HCl) matched the formulation context and did not validate the prediction against literature before concluding.

### Feedback:
- Always clarify and use the pharmaceutically relevant chemical form. For ketamine in formulation contexts, that is ketamine HCl, not the free base. If uncertain, ask or compute both.
- Validate ML predictions against experimental data or pharmacopeial/label references before concluding. Here, recent experimental data show ethanol solubility for ketamine HCl is < ~27 mg/mL at 25°C, far below your 114 g/L figure. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/))
- Be cautious converting qualitative descriptors (“soluble,” “freely soluble”) into numeric claims; when numeric conflicts arise (e.g., NCATS/WHO listing ~750 g/L vs. experimental findings), discuss discrepancies and prioritize primary experimental sources. ([drugs.ncats.io](https://drugs.ncats.io/substance/O18YUO0I83?utm_source=openai))
- For formulation advice, report: chemical form, solvent grade (e.g., ethanol 95% vs absolute), temperature, and units (mg/mL) with uncertainty, and consider pH/speciation effects that dramatically alter ketamine solubility in aqueous media. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/))
- Provide the final recommended value explicitly for the asked context (e.g., “ketamine HCl in ethanol at 25°C: on the order of 10–25 mg/mL”), and avoid overgeneralizing from a single ML prediction.
- Literature validation: Agent’s computed value:
- Ketamine free base in ethanol at 25°C: logS = −0.316 → S ≈ 0.48 mol/L → ≈114 g/L (MW ≈ 237.7 g/mol).

Literature values (pharmaceutically relevant salt: ketamine HCl):
- Experimental study (25°C): Methanol 269.9 ± 25.4 mg/mL; ethanol “>10× lower than methanol,” implying ethanol < 27 mg/mL at 25 °C. Source: Idoudi et al., Pharmaceutics 2024; Figure 4 and text. https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/ ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/))
- Supplier technical sheet examples (ketamine HCl): ethanol 10 mg/mL maximum stock commonly listed. Example: Cayman via Biomol “Ethanol: 10 mg/mL.” https://www.biomol.com/products/chemicals/reference-standards/ketamine-hydrochloride-cay11630-1 ([biomol.com](https://www.biomol.com/products/chemicals/reference-standards/ketamine-hydrochloride-cay11630-1?utm_source=openai))
- Secondary database citing WHO International Pharmacopoeia: “soluble in ethanol (~750 g/L).” Likely inconsistent with “soluble” descriptor and experimental data. https://drugs.ncats.io/substance/O18YUO0I83 ([drugs.ncats.io](https://drugs.ncats.io/substance/O18YUO0I83?utm_source=openai))

Comparison (using experimental ethanol bound as the primary reference):
- Literature value (HCl in ethanol, 25°C): ≤ 27 mg/mL (= ≤ 27 g/L).
- Absolute error: ≥ |114 − 27| = ≥ 87 g/L.
- Percent error: ≥ (87/27) × 100% = ≥ 322%.
- Score justification: The agent answered for the wrong chemical form (free base) and the value is off by more than a factor of 3 relative to experimental ethanol solubility for the pharmaceutical salt at room temperature, which exceeds the >150% error threshold → 0/2.

Secondary check against NCATS/WHO IP number (not preferred due to inconsistency):
- Literature value: 750 g/L (HCl, ethanol).
- Absolute error: |114 − 750| = 636 g/L.
- Percent error: 636/750 × 100% ≈ 84.8% (would score 1/2 if this value were trusted). Given the contradiction with experimental data and qualitative pharmacopeial descriptors, we prioritize the experimental reference above.

### Web Search Citations:
1. [
            Investigating Strategies to Enhance the Aqueous Solubility of Ketamine HCl for Intranasal Delivery - PMC
        ](https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/)
2. [Ketamine (hydrochloride) | CAS 1867-66-9 | Cayman Chemical | Biomol.com](https://www.biomol.com/products/chemicals/reference-standards/ketamine-hydrochloride-cay11630-1?utm_source=openai)
3. [KETAMINE HYDROCHLORIDE](https://drugs.ncats.io/substance/O18YUO0I83?utm_source=openai)
4. [
            Investigating Strategies to Enhance the Aqueous Solubility of Ketamine HCl for Intranasal Delivery - PMC
        ](https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/)
5. [KETAMINE HYDROCHLORIDE](https://drugs.ncats.io/substance/O18YUO0I83?utm_source=openai)
6. [
            Investigating Strategies to Enhance the Aqueous Solubility of Ketamine HCl for Intranasal Delivery - PMC
        ](https://pmc.ncbi.nlm.nih.gov/articles/PMC11677332/)

### Execution:
- **Tools**: retrieve_workflow, molecule_lookup, submit_solubility_workflow, workflow_get_status
- **Time**: 3.0 min

---
*Evaluated with openai/gpt-5*
